AndreaBozzo/ceres-open-data-index huggingface dataset:
Nitroglycerin

Nitroglycerin is a prescription medication used to relieve chest pain (angina) caused by coronary artery disease. It works as a nitrate vasodilator to widen blood vessels and improve blood flow to the heart. Available as sublingual tablets in strengths of 0.3mg, 0.4mg, and 0.6mg, placed under the tongue for quick relief. Manufactured by Advagen Pharma Ltd under ANDA209779. This information was generated using AI and is provided for informational and research purposes only.
Patent AT-E40151-T1: [Translated] BLEACH COMPOSITIONS.

Aqueous hypochlorite bleach compositions are provided comprising from 0.1% to 5.0% of a C10-C18 alkyl C1-C4 alkyl diamine oxide or a C8-C18 alkyl substituted betaine together with from 0.001% to 0.25% of an organosilicon quaternary ammonium compound containing a C16-C20 alkyl group wherein the ionic strength ofthe compositions is less than 5.0 g moles/dm<3>.
Patent AT-E399626-T1: [Translated] METHOD FOR PRODUCING FILLED GRANULES FROM HIGH OR ULTRA HIGH MOLECULAR WEIGHT

Filled pelletized materials made from high- or ultrahigh-molecular-weight polyethylenes and process for their production Pelletized materials made from high- and/or ultrahigh-molecular-weight polyethylene are described. The pelletized materials comprise fillers and/or reinforcing materials and can be processed by processes known per se to give moldings. The pelletized materials may be produced on a specifically designed extruder.
Publications Using SAMHSA DataDrug Abuse Warning Network, 2010: Area Profiles of Drug-related Mortality

The findings in this publication reflect data on drug-related deaths that occurred during calendar year 2010 and were reported by participating medical examiners/coroners (ME/Cs) to DAWN.  Data are not nationally representative but cover metropolitan areas in 37 states, with complete data for 13 states. Counts of drug-related deaths for (1) drug-related deaths (non-suicide), and (2) drug-related suicide deaths. Tables include counts for major drugs/drug categories with comparisons to 2009, manner of death, rates by sex and age, top 5 drugs and place of death.
Compound 528355: (1Z)-1-(4-Pyridinyl)ethanone N-cyclohexylthiosemicarbazone

Chemical compound data from PubChem database. IUPAC Name: 2-decanoyloxybutyl decanoate. Molecular Formula: C24H46O4. Molecular Weight: 398.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530260: 1,3,5-tris-(Hydroxymethyl)benzene triacetate

Chemical compound data from PubChem database. IUPAC Name: [3,5-bis(acetyloxymethyl)phenyl]methyl acetate. Molecular Formula: C15H18O6. Molecular Weight: 294.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401767-T1: [Translated] SURFACE TREATED COPPER FOIL AND PRODUCTION THEREOF AND COPPER CLADDED LAMINATE THEREOF

The invention provides a surface-treated copper foil for producing printed wiring boards whose surface has,,been subjected to nodular treatment and anti-corrosion treatment, wherein the anti-corrosion treatment includes forming a-zinc-copper-tin ternary alloy anti-corrosive plating layer on a surface of the copper foil; forming an electrolytic chromate layer on the anti-corrosive plating layer; forming a silane-coupling-agent-adsorbed layer on the electrolytic chromate layer; and drying the copper foil for 2-6 seconds such that the copper foil reaches 105° C.-200° C.
Compound 529211: Cyclohexanamine, 3-methyl, mono-TMS

Chemical compound data from PubChem database. IUPAC Name: 3-methyl-N-trimethylsilylcyclohexan-1-amine. Molecular Formula: C10H23NSi. Molecular Weight: 185.38. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
National Head Start/Public School Early Childhood Transition Demonstration Study, 1991-1999

The National Transition Demonstration Study was conducted to provide information about the implementation of this program and its impact on children, families, schools, and communities. The study design involved random assignment of schools to a Transition Demonstration group, which received additional supports and staff funded by this project, or to a Comparison group. A total of 7,515 former Head Start children and families were enrolled in the National Study in 1992/93 and 1993/94. Thousands of other children and families, however, participated in the Transition Demonstration Program, since supports and educational enhancements were offered to all children and families in the classrooms.

<b>Units of Response: </b>Children and Families, Head Start Programs

<b>Type of Data: </b>Evaluation

<b>Tribal Data: </b>Yes

<b>COVID-19 Data: </b>No

<b>Periodicity: </b>One-time

<b>SORN: </b>https://www.federalregister.gov/documents/2015/04/02/2015-07440/privacy-act-of-1974-system-of-records-notice

<b>Data Use Agreement: </b>https://www.icpsr.umich.edu/rpxlogin

<b>Data Use Agreement Location: </b>https://www.childandfamilydataarchive.org/cfda/archives/cfda/studies/4712/datadocumentation

<b>Equity Indicators: </b>Gender Identity;Household Income;Household Size

<b>Granularity: </b>Household;Individual;Program

<b>Spatial: </b>United States

<b>Geocoding: </b>City;State
Compound 526906: 2-Isobutoxyethyl TMS ether

Chemical compound data from PubChem database. IUPAC Name: trimethyl-[2-(2-methylpropoxy)ethoxy]silane. Molecular Formula: C9H22O2Si. Molecular Weight: 190.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400225-T1: [Translated] PATELLA RESECTION DEVICE

A patellar resection tool has first and second gripping members adapted for relative movement between a closed position in which the patella can be held between the gripping members and an open position in which the patella can be released. The tool also has first and second handle members connected to the first and second gripping members respectively, for moving the gripping members between the open and closed positions.  The first and second handle members are constrained for relative movement in a first plane and the first and second gripping members are constrained for relative movement in a second plane which is not parallel to the first plane.  This allows the tool to be used in a minimally invasive surgical technique in which a patella is everted by an angle less than 90° without obstructing access to the patella.
National Violent Death Reporting System (NVDRS)

<p>The National Violent Death Reporting System (NVDRS) provides states and communities with a clearer understanding of violent deaths to guide local decisions about efforts to prevent violence and helps them track progress over time.</p>
<p>To stop violent deaths, we must first understand all the facts. Created in 2002, the NVDRS is a surveillance system that pulls together data on violent deaths in 18 states (see map below), including information about homicides, such as homicides perpetrated by a intimate partner (e.g., boyfriend, girlfriend, wife, husband), child maltreatment (or child abuse) fatalities, suicides, deaths where individuals are killed by law enforcement in the line of duty, unintentional firearm injury deaths, and deaths of undetermined intent.</p>
<p>These data are supported by WISQARS, an interactive query system that provides data on injury deaths, violent deaths, and nonfatal injuries.</p>
Publications Using SAMHSA Data2015 CMHS Uniform Reporting System (URS) Table for Republic of Palau

2015 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Republic of Palau. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
ARCHIVED: Mpox Vaccinations Given to SF Residents Over Time

<strong>In early February 2024, we will be retiring the Mpox Vaccinations Given to SF Residents Over Time dataset. This dataset will be archived and no longer update. A historic record of this data will remain available </strong>

<strong>A. SUMMARY </strong>
This dataset represents doses of mpox vaccine (JYNNEOS) administered in California to residents of San Francisco ages 18 years or older. This dataset only includes doses of the JYNNEOS vaccine given on or after 5/1/2022. All vaccines given to people who live in San Francisco are included, no matter where the vaccination took place.

<strong>B. HOW THE DATASET IS CREATED </strong>
Information on doses administered to those who live in San Francisco is from the  <a href="https://cdph.ca.gov/CAIR">California Immunization Registry (CAIR2)</a>, run by the California Department of Public Health (CDPH).

<strong>C. UPDATE PROCESS </strong>
Updated daily via automated process.

<strong>D. HOW TO USE THIS DATASET </strong>
Each row reflects the number of first, second, and total doses administered on that date and up through that date.

<strong>E. CHANGE LOG </strong>
<ul><li>UPDATE 1/3/2023: Due to low case numbers, this page will no longer include vaccinations after 12/31/2022.</li></ul>
Department of Human Services(DHS) Family Investment Administration Program Caseloads

Food Supplement Program (FSP) active cases are the number of total cases that are active at the end of the FSP benefit receiving month and for the following month. These cases are active because they are compliant with all FSP eligibility requirements.

Expedited Food Supplement Program approved cases are FSP cases that meet the expedited requirements and FSP eligibility requirements. 

Note: If expedited FSP cases remain active at the end of the application month, they will be included in the overall active FSP cases
Monthly Cumulative Number and Percent of Adults 75 Years and Older Who Received 1+ RSV Vaccination Doses by Jurisdiction, United States

• Monthly Cumulative Percent of Adults 75 Years and Older Who Received 1+ RSV Vaccination Doses by Jurisdiction, United States. 
• Respiratory Syncytial Virus (RSV) vaccination coverage for adults is assessed through U.S. jurisdictions’ Immunization Information Systems Resources (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group (https://www.cdc.gov/iis/about/).
Behavioral Risk Factor Surveillance Survey: 2024

The Behavioral Risk Factor Surveillance System (BRFSS) is an annual statewide telephone surveillance system designed by the Centers for Disease Control and Prevention (CDC). BRFSS monitors modifiable risk behaviors and other factors contributing to the leading causes of morbidity and mortality in the population. New York State's BRFSS sample represents the adult population living in private residences or college housing who have either a landline or cellular telephone, aged 18 years and older. Adults living in group homes or congregate settings are excluded from the survey. Although the overall number of respondents in the BRFSS is more than sufficiently large for statistical inference purposes, subgroup analyses can lead to estimates that are unreliable. Interpreting and reporting weighted numbers that are based on a small, unweighted number of respondents can mislead the reader into believing that a given finding is much more precise than it actually is. The BRFSS follows a rule of not reporting or interpreting percentages based upon a denominator of fewer than 50 respondents (unweighted sample). Both a csv and sas data files are available.
Bempedoic acid and ezetimibe

Nexlizet is a prescription tablet combining bempedoic acid (180 mg) and ezetimibe (10 mg) to help lower cholesterol levels. It works by reducing cholesterol production in the liver and blocking its absorption from food. Taken orally, it's used for adults with high cholesterol who need additional treatment. This information was generated using AI and is provided for informational and research purposes only.
NNDSS - Table II. Hepatitis (viral, acute, by type) A & B

NNDSS - Table II. Hepatitis (viral, acute, by type) A & B - 2018. In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states or territory.

Note:

This table contains provisional cases of selected national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up.  Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html.
 
Footnotes:

C.N.M.I.: Commonwealth of Northern Mariana Islands. 
U: Unavailable. —: No reported cases. N: Not reportable. NA:  Not Available.  NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts. Med: Median. Max: Maximum. 

* Case counts for reporting years 2017 and 2018 are provisional and subject to change. Data for years 2013 through 2016 are finalized. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf.  

† Perinatal hepatitis C cases are not included in this table. These data will be included in the annual NNDSS tables on the NNDSS Data and Statistics page (https://wwwn.cdc.gov/nndss/data-and-statistics.html) beginning with data year 2018 and in the annual Summary of Viral Hepatitis, published online by CDC's Division of Viral Hepatitis, available at https://www.cdc.gov/hepatitis/statistics/2015surveillance/index.htm.
Patent AT-E401499-T1: [Translated] ASSEMBLY OF A ROTATING ELECTRIC MACHINE FOR AN AUTOMOBILE VEHICLE

The invention relates to a rotating electrical machine assembly (2) for a motor vehicle. The invention comprises a rotor (6) surrounded by a stator (5) which is solidly connected to a spacer (61) that is disposed between the casing (62) of the engine of the motor vehicle having a crankshaft (11) and a dome (14). The invention is characterised in that the dome (14) is used to house the casing (3) of a hydrokinetic coupling device comprising an axially-projecting centring nozzle (30) with a closed free end. Moreover, the invention is characterised in that a first drive unit (12) connects the crankshaft (11) of the engine of the vehicle to a hollow rigid support (13) bearing the rotor (6) and in that a second drive unit (15, 4) is connected to the casing (3) of the hydrokinetic coupling device. The invention is further characterised in that: said two drive units (12, 15) are interconnected by means of a link comprising complementary forms (241, 341) consisting of an axially-oriented contour (241) which is supported by the first drive unit (12)and which co-operates in a complementary manner with an axially-oriented counter contour (341) which is supported by the second drive unit (15, 4), and in that the contour and the counter contour penetrate the support.
Aged garlic extract therapy for sickle cell anemia patients

Background
          Sickle cell anemia is one of the most prevalent hereditary disorders with prominent morbidity and mortality. With this disorder oxidative, phenomena play a significant role in its pathophysiology. One of the garlic (Allium sativum L.) formulations, aged garlic extract (AGE), has been reported to exert an anti-oxidant effect in vitro, we have evaluated the anti-oxidant effect of AGE on sickle red blood cells (RBC).
        
        
          Methods
          Five patients (two men and three women, mean age 40 ± 15 years, range 24–58 years) with sickle cell anemia participated in the study. AGE was administered at a dose of 5 ml a day. Whole blood samples were obtained at baseline and at 4 weeks for primarily Heinz body analysis.
        
        
          Results
          The data were consistent with our hypothesis. In all patients, the number of Heinz bodies decreased over the 4 week period (58.9 ± 20.0% at baseline to 29.8 ± 15.3% at follow-up, p = 0.03).
        
        
          Conclusions
          These data suggest that there is a significant anti-oxidant activity of AGE on sickle RBC. AGE may be further evaluated as a potential therapeutic agent to ameliorate complications of sickle cell anemia.
Research Article: BMC Pharmacology

Background
          Evidence suggests that both the migration and activation of neutrophils into the airway is of importance in pathological conditions such as pulmonary emphysema. In the present study, we describe in vivo models of lung neutrophil infiltration and activation in mice and hamsters.
        
        
          Results
          BALB/c and C57BL/6 mice were intranasally treated with lipopolysaccharide (0.3 mg/kg). Twenty-four hours after, animals were treated intranasally with N-Formyl-Met-Leu-Phe (0 to 5 mg/kg). Golden Syrian hamsters were treated intratracheally with 0.5 mg/kg of lipopolysaccharide. Twenty-four hours after, animals were treated intratracheally with 0.25 mg/kg of N-Formyl-Met-Leu-Phe. Both mice and hamster were sacrificed two hours after the N-Formyl-Met-Leu-Phe application. In both BALB/c and C57BL/6 mice, a neutrophil infiltration was observed after the sequential application of lipopolysaccharide and N-Formyl-Met-Leu-Phe. However, 5 times less neutrophil was found in C57BL/6 mice when compared to BALB/c mice. This was reflected in the neutrophil activation parameters measured (myeloperoxidase and elastase activities). Despite the presence of neutrophil and their activation status, no lung haemorrhage could be detected in both strains of mice. When compared with mice, the lung inflammation induced by the sequential application of lipopolysaccharide and N-Formyl-Met-Leu-Phe was much greater in the hamster. In parallel with this lung inflammation, a significant lung haemorrhage was also observed.
        
        
          Conclusions
          Both mouse and hamster can be used for pharmacological studies of new drugs or other therapeutics agents that aimed to interfere with neutrophil activation. However, only the hamster model seems to be suitable for studying the haemorrhagic lung injury process.
Compound 527595: 3-Buten-1-ol, trichloroacetate

Chemical compound data from PubChem database. IUPAC Name: but-3-enyl 2,2,2-trichloroacetate. Molecular Formula: C6H7Cl3O2. Molecular Weight: 217.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399995-T1: [Translated] METHOD, DEVICE AND SYSTEM FOR FREQUENCY STABILIZATION USING CELLULAR SIGNAL PULSE

A system, apparatus and corresponding method for providing a frequency reference to a user module, such as a global positioning system (GPS) receiver module. The method includes the steps of: a) having a cellular module respond to a cellular communication signal by providing a trigger pulse derived from the data component of the cellular communication signal; and b) directing the trigger pulse along a special hardware path leading from the cellular module to a user module. The special hardware path conducts the trigger pulse in such a way that the trigger pulse is provided to the user module substantially free of any significant random delays. The user module typically includes a frequency generation module that provides a stable frequency reference based on the trigger pulse. In some applications, the method also includes the step of identifying each new frame or time slot or data bit in the cellular communication signal, and the trigger pulse is provided each time a new frame or time slot or data bit, respectively, is identified.
Prediction of co-regulated genes in

Background
          Identification of co-regulated genes is essential for elucidating transcriptional regulatory networks and the function of uncharacterized genes. Although co-regulated genes should have at least one common sequence element, it is generally difficult to identify these genes from the presence of this element because it is very easily obscured by noise. To overcome this problem, we used conserved information from three closely related species: Bacillus subtilis, B. halodurans and B. stearothermophilus.
        
        
          Results
          Even though such species have a limited number of clearly orthologous genes, we obtained 1,884 phylogenetically conserved elements from the upstream intergenic regions of 1,568 B. subtilis genes. Similarity between these elements was used to cluster these genes. No other a priori knowledge on genes and elements was used. We could identify some genes known or suggested to be regulated by a common transcription factor as well as genes regulated by a common attenuation effector.
        
        
          Conclusions
          We confirmed that our method generates relatively few false positives in clusters with higher scores and that general elements such as -35/-10 boxes and Shine-Dalgarno sequence are not major obstacles. Moreover, we identified some plausible additional members of groups of known co-regulated genes. Thus, our approach is promising for exploring potentially co-regulated genes.